1-18 of 18
Authors: Masoud H Manjili
Sort by
Journal Article
The adaptation model of immunity: tumor cell adaptation to tumor-reactive immune responses
Get access
Masoud H Manjili
The Journal of Immunology, Volume 210, Issue Supplement_1, May 2023, Page 88.01, https://doi.org/10.4049/jimmunol.210.Supp.88.01
Published: 01 May 2023
Journal Article
A shift in the hepatic immunological pattern from predominant adaptive immunity to innate immunity compromises tissue-specific immunity and leads to HCC
Get access
Nicholas James Koelsch and others
The Journal of Immunology, Volume 210, Issue Supplement_1, May 2023, Page 89.02, https://doi.org/10.4049/jimmunol.210.Supp.89.02
Published: 01 May 2023
Journal Article
Restoration of CD4+ T helper cells without modulating the hepatic inflammatory pattern is not sufficient to prevent HCC
Get access
Masoud H Manjili and others
The Journal of Immunology, Volume 210, Issue Supplement_1, May 2023, Page 245.15, https://doi.org/10.4049/jimmunol.210.Supp.245.15
Published: 01 May 2023
Journal Article
The adaptation model of immunity: allograft rejection versus allograft adaptation
Get access
Masoud H Manjili
The Journal of Immunology, Volume 210, Issue Supplement_1, May 2023, Page 173.23, https://doi.org/10.4049/jimmunol.210.Supp.173.23
Published: 01 May 2023
Journal Article
The adaptation model of immunity: signal IV matters most in determining the functional outcomes of immune responses
Get access
Masoud H Manjili
The Journal of Immunology, Volume 210, Issue Supplement_1, May 2023, Page 77.15, https://doi.org/10.4049/jimmunol.210.Supp.77.15
Published: 01 May 2023
Journal Article
System biology or pattern recognition of the immune response for offering immunotherapeutic cures for human diseases
Get access
Masoud H Manjili and Nicholas Koelsch
The Journal of Immunology, Volume 210, Issue Supplement_1, May 2023, Page 153.10, https://doi.org/10.4049/jimmunol.210.Supp.153.10
Published: 01 May 2023
Journal Article
The Adaptation Model of Immunity: Signal IV Matters Most in Determining the Functional Outcomes of Immune Responses
Get access
Masoud H Manjili
The Journal of Immunology, Volume 210, Issue 5, March 2023, Pages 521–530, https://doi.org/10.4049/jimmunol.2200672
Published: 01 March 2023
Journal Article
COVID-19 as an Acute Inflammatory Disease Purchased
Rose H Manjili and others
The Journal of Immunology, Volume 205, Issue 1, July 2020, Pages 12–19, https://doi.org/10.4049/jimmunol.2000413
Published: 01 July 2020
Journal Article
Autophagy-deficient breast cancer shows early escape from dormancy and recurrence following chemotherapy
Get access
Hussein F Aqbi and others
The Journal of Immunology, Volume 200, Issue Supplement_1, May 2018, Page 122.23, https://doi.org/10.4049/jimmunol.200.Supp.122.23
Published: 01 May 2018
Journal Article
Low-dose chemotherapy induces immunogenic tumor dormancy in mouse mammary carcinoma cells
Get access
Timothy M Smith and others
The Journal of Immunology, Volume 198, Issue Supplement_1, May 2017, Page 204.14, https://doi.org/10.4049/jimmunol.198.Supp.204.14
Published: 01 May 2017
Journal Article
Chemotherapy-induced tumor dormancy and relapse
Get access
Hussein F Aqbi and others
The Journal of Immunology, Volume 198, Issue Supplement_1, May 2017, Page 204.7, https://doi.org/10.4049/jimmunol.198.Supp.204.7
Published: 01 May 2017
Journal Article
Host-protective anti-tumor immune responses induce immunoediting of indolent but not quiescent dormant tumor cells
Get access
Masoud H Manjili and others
The Journal of Immunology, Volume 196, Issue 1_Supplement, May 2016, Page 212.8, https://doi.org/10.4049/jimmunol.196.Supp.212.8
Published: 01 May 2016
Journal Article
Cutting Edge: Mast Cells Critically Augment Myeloid-Derived Suppressor Cell Activity
Get access
Sheinei J Saleem and others
The Journal of Immunology, Volume 189, Issue 2, July 2012, Pages 511–515, https://doi.org/10.4049/jimmunol.1200647
Published: 15 July 2012
Journal Article
Activated NKT Cells and NK Cells Render T Cells Resistant to Myeloid-Derived Suppressor Cells and Result in an Effective Adoptive Cellular Therapy against Breast Cancer in the FVBN202 Transgenic Mouse
Get access
Maciej Kmieciak and others
The Journal of Immunology, Volume 187, Issue 2, July 2011, Pages 708–717, https://doi.org/10.4049/jimmunol.1100502
Published: 15 July 2011
Journal Article
Comment on “Cutting Edge: CD8+ T Cell Priming in the Absence of NK Cells Leads to Enhanced Memory Responses”
Get access
Masoud H Manjili and Amir Toor
The Journal of Immunology, Volume 186, Issue 11, June 2011, Page 6071, https://doi.org/10.4049/jimmunol.1190017
Published: 01 June 2011
Journal Article
The status of IFN-gamma receptor on tumor cells will determine the outcome of tumor relapse or tumor-free survival in FVB mice (50.7)
Get access
Maciej Kmieciak and others
The Journal of Immunology, Volume 178, Issue 1_Supplement, April 2007, Page S91, https://doi.org/10.4049/jimmunol.178.Supp.50.7
Published: 01 April 2007
Journal Article
Comment on “Tumor Progression Can Occur despite the Induction of Very High Levels of Self/Tumor Antigen-Specific CD8+ T Cells in Patients with Melanoma”
Get access
Masoud H Manjili and others
The Journal of Immunology, Volume 176, Issue 8, April 2006, Page 4511, https://doi.org/10.4049/jimmunol.176.8.4511
Published: 15 April 2006
Journal Article
HSP110-HER2/neu Chaperone Complex Vaccine Induces Protective Immunity Against Spontaneous Mammary Tumors in HER-2/neu Transgenic Mice
Get access
Masoud H Manjili and others
The Journal of Immunology, Volume 171, Issue 8, October 2003, Pages 4054–4061, https://doi.org/10.4049/jimmunol.171.8.4054
Published: 15 October 2003